Compliance and Infection Prevention Benefits Drive Growth of Unit Dose Pharmaceutical Containers


CLEVELAND, December 16, 2021 / PRNewswire / – New Analysis From The Freedonia Group On The Global Pharmaceutical Market Predicts Good Prospects For Single-Dose Containers Through 2025 Due To Their compliance and the benefits of infection prevention.

Increased efforts to improve patient adherence to medication programs – both routinely and for clinical trials – will promote the increasing use of blister packs and blisters, single-dose sachets and other unit-dose containers in clinical trials. oral and topical pharmaceutical packaging.

By 2025, single-dose pre-filled syringes and glass vials will generate the fastest unit growth and revenue among all pharmaceutical packaging because they:

  • prevent cross-contamination and the spread of infection
  • are commonly used to deliver parenteral drugs and vaccines against bacterial and viral diseases and cancer

The global pharmaceutical packaging market to overtake 110 billion dollars in 2025
The Freedonia Group predicts that the demand for pharmaceutical packaging will increase by 6.0% per year to reach $ 112 billion in 2025. Several ongoing and emerging trends will underpin gains, in particular a steady growth in the value of global pharmaceutical production, such as the use of ethical and over-the-counter (OTC) medicines, dietary supplements based on herbal and non-herbal and nutritional preparations continue to rise.

Several trends and factors will drive the growth of global pharmaceutical production over the coming years, including:

  • growing need for drugs and related preparations due to an aging population and increasing levels of acute and chronic disease
  • the growing adoption of health care cost containment strategies that encourage people to self-medicate minor illnesses
  • advances in biotechnology, nanotechnology and other drug discovery technologies that will lead to the introduction of corresponding advanced drugs
  • the increasing substitution of drug therapies for surgery and other more expensive medical procedures as a cost saving measure, whenever possible
  • expansion and modernization of drug-producing industries in many developing countries as part of efforts to improve the availability and accessibility of basic drugs

You want to know more ?

Global pharmaceutical packaging is now available from the Freedonia Group. This study provides historical data (2010, 2015, 2020) and demand forecast for 2025 and 2030 for pharmaceutical packaging in millions of US dollars (including inflation) by product, geographic region and selected countries. Unit demands for the same years are provided for most product groups. Material trends (plastic, glass, paper / cardboard, metal / foil) and company analysis including market share are also provided.

Some products:

  • bottles and jars
  • blister packaging
  • pre-fillable syringes (injectors and cartridge holders)
  • parenteral vials and ampoules, including glass and plastic types
  • IV containers (semi-rigid plastic IV containers, flexible mini IV bags and glass IV containers)
  • boxes and cartons (folding boxes and cartons, corrugated cardboard installation boxes and shipping containers
  • pouches, including paper, plastic and aluminum foil types
  • tubes, including composite tubes, plastic tubes and bendable metal tubes
  • other packaging (prescription boxes, strip packs, etc.)

Pharmaceutical caps and closures, labels and packaging accessories are excluded, unless otherwise specified.

About the Freedonia Group – The Freedonia Group, a division of, is the leading international industrial research company, providing our clients with product analyzes, market forecasts, industry trends and market share information. From individual consulting firms to global conglomerates, our analysts provide businesses with unbiased and reliable market research and analysis to help them make important business decisions. With over 100 studies published each year, we support over 90% of Fortune 500 industrial companies. Find off-the-shelf studies at or contact us for a personalized search: +1 440.842.2400.

Press contact:
Corinne Gangloff
+1 440.842.2400
[email protected]

SOURCE The Freedonia Group


Comments are closed.